Azaj Ahmed1, Anas Shamsi1, Taj Mohammad1, Gulam Mustafa Hasan2, Asimul Islam1, Md Imtaiyaz Hassan3. 1. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India. 2. Department of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj, 11942, Kingdom of Saudi Arabia. 3. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India. mihassan@jmi.ac.in.
Abstract
BACKGROUND: Ensuring genetic integrity is essential during the cell cycle to avoid aneuploidy, one of the underlying causes of malignancies. Aurora kinases are serine/threonine kinase that play a vital role in maintaining the genomic integrity of the cells. There are three forms of aurora kinases in the mammalian cells, which are highly conserved and act together with several other proteins to control chromosome alignment and its equal distribution to daughter cells in mitosis and meiosis. METHODS: We provide here a detailed analysis of Aurora B kinase (ABK) in terms of its expression, structure, function, disease association and potential therapeutic implications. RESULTS: ABK plays an instrumental in mitotic entry, chromosome condensation, spindle assembly, cytokinesis, and abscission. Small-molecule inhibitors of ABK are designed and synthesized to control cancer progression. A detailed understanding of ABK pathophysiology in different cancers is of great significance in designing and developing effective therapeutic strategies. CONCLUSION: In this review, we have discussed the physiological significance of ABK followed by its role in cancer progression. We further highlighted available small-molecule inhibitors to control the tumor proliferation and their mechanistic insights.
BACKGROUND: Ensuring genetic integrity is essential during the cell cycle to avoid aneuploidy, one of the underlying causes of malignancies. Aurora kinases are serine/threonine kinase that play a vital role in maintaining the genomic integrity of the cells. There are three forms of aurora kinases in the mammalian cells, which are highly conserved and act together with several other proteins to control chromosome alignment and its equal distribution to daughter cells in mitosis and meiosis. METHODS: We provide here a detailed analysis of Aurora B kinase (ABK) in terms of its expression, structure, function, disease association and potential therapeutic implications. RESULTS: ABK plays an instrumental in mitotic entry, chromosome condensation, spindle assembly, cytokinesis, and abscission. Small-molecule inhibitors of ABK are designed and synthesized to control cancer progression. A detailed understanding of ABK pathophysiology in different cancers is of great significance in designing and developing effective therapeutic strategies. CONCLUSION: In this review, we have discussed the physiological significance of ABK followed by its role in cancer progression. We further highlighted available small-molecule inhibitors to control the tumor proliferation and their mechanistic insights.
Entities:
Keywords:
Aneuploidy; Aurora kinase; Cancer therapeutics; Cell cycle regulation; Small molecule inhibitors
Authors: J R Bischoff; L Anderson; Y Zhu; K Mossie; L Ng; B Souza; B Schryver; P Flanagan; F Clairvoyant; C Ginther; C S Chan; M Novotny; D J Slamon; G D Plowman Journal: EMBO J Date: 1998-06-01 Impact factor: 11.598
Authors: A Azzariti; G Bocci; L Porcelli; A Fioravanti; P Sini; G M Simone; A E Quatrale; P Chiarappa; A Mangia; S Sebastian; D Del Bufalo; M Del Tacca; A Paradiso Journal: Br J Cancer Date: 2011-02-08 Impact factor: 7.640
Authors: David Bebbington; Hayley Binch; Jean-Damien Charrier; Simon Everitt; Damien Fraysse; Julian Golec; David Kay; Ronald Knegtel; Chau Mak; Francesca Mazzei; Andrew Miller; Michael Mortimore; Michael O'Donnell; Sanjay Patel; Francoise Pierard; Joanne Pinder; John Pollard; Sharn Ramaya; Daniel Robinson; Alistair Rutherford; John Studley; James Westcott Journal: Bioorg Med Chem Lett Date: 2009-05-03 Impact factor: 2.823
Authors: Dominik Bogen; Jun S Wei; David O Azorsa; Pinar Ormanoglu; Eugen Buehler; Rajarshi Guha; Jonathan M Keller; Lesley A Mathews Griner; Marc Ferrer; Young K Song; Hongling Liao; Arnulfo Mendoza; Berkley E Gryder; Sivasish Sindri; Jianbin He; Xinyu Wen; Shile Zhang; John F Shern; Marielle E Yohe; Sabine Taschner-Mandl; Jason M Shohet; Craig J Thomas; Scott E Martin; Peter F Ambros; Javed Khan Journal: Oncotarget Date: 2015-11-03